Armata Pharmaceuticals, Inc.ARMPNYSE
Loading
Year-over-year operating income growth rate
Percentile
P41
Within normal range
vs 3Y Ago
-2.1x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -13.62% |
| Q2 2025 | 16.44% |
| Q1 2025 | 22.28% |
| Q4 2024 | -8.03% |
| Q3 2024 | 18.11% |
| Q2 2024 | -16.48% |
| Q1 2024 | -6.78% |
| Q4 2023 | 7.32% |
| Q3 2023 | -7.34% |
| Q2 2023 | 15.13% |
| Q1 2023 | -9.86% |
| Q4 2022 | -19.77% |
| Q3 2022 | 6.48% |
| Q2 2022 | -5.07% |
| Q1 2022 | -45.09% |
| Q4 2021 | 1.55% |
| Q3 2021 | 0.86% |
| Q2 2021 | -14.00% |
| Q1 2021 | 15.78% |
| Q4 2020 | -14.76% |
| Q3 2020 | -22.51% |
| Q2 2020 | 6.73% |
| Q1 2020 | -32.53% |
| Q4 2019 | 45.21% |
| Q3 2019 | -31.39% |
| Q2 2019 | -49.90% |
| Q1 2019 | 28.01% |
| Q4 2018 | -192.00% |
| Q3 2018 | 46.36% |
| Q2 2018 | 0.10% |
| Q1 2018 | -29.18% |
| Q4 2017 | -217.02% |
| Q3 2017 | 92.30% |
| Q2 2017 | -188.36% |
| Q1 2017 | -44.97% |
| Q4 2016 | 31.99% |
| Q3 2016 | 5.07% |
| Q2 2016 | 20.56% |
| Q1 2016 | -53.67% |
| Q4 2015 | -21.09% |